A detailed history of Plancorp, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Plancorp, LLC holds 11,286 shares of IONS stock, worth $412,277. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,286
Previous 11,286 -0.0%
Holding current value
$412,277
Previous $537,000 15.83%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$36.45 - $47.7 $4,774 - $6,248
131 Added 1.17%
11,286 $537,000
Q2 2023

Jul 26, 2023

SELL
$34.73 - $43.33 $69 - $86
-2 Reduced 0.02%
11,155 $457,000
Q1 2023

May 11, 2023

SELL
$33.58 - $41.2 $1,846 - $2,266
-55 Reduced 0.49%
11,157 $398,000
Q4 2022

Feb 14, 2023

SELL
$37.12 - $46.52 $1,596 - $2,000
-43 Reduced 0.38%
11,212 $423,000
Q3 2022

Nov 10, 2022

BUY
$36.54 - $48.66 $730 - $973
20 Added 0.18%
11,255 $498,000
Q2 2022

Aug 04, 2022

BUY
$31.71 - $43.0 $729 - $989
23 Added 0.21%
11,235 $416,000
Q1 2022

May 13, 2022

SELL
$29.88 - $37.04 $1,852 - $2,296
-62 Reduced 0.55%
11,212 $415,000
Q4 2021

Feb 11, 2022

BUY
$25.61 - $35.1 $3,585 - $4,914
140 Added 1.26%
11,274 $343,000
Q3 2021

Nov 15, 2021

BUY
$33.54 - $40.55 $469 - $567
14 Added 0.13%
11,134 $373,000
Q2 2021

Aug 13, 2021

BUY
$34.54 - $47.25 $690 - $945
20 Added 0.18%
11,120 $444,000
Q4 2020

Feb 09, 2021

SELL
$45.3 - $60.27 $906 - $1,205
-20 Reduced 0.18%
11,100 $628,000
Q3 2020

Nov 16, 2020

BUY
$47.45 - $62.95 $527,644 - $700,004
11,120 New
11,120 $528,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.19B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Plancorp, LLC Portfolio

Follow Plancorp, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plancorp, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plancorp, LLC with notifications on news.